Flu and RSV are packing a post-holiday one-two punch, sending people into Erie's emergency departments and medical offices ...

US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, with health experts warning ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.

The novel treatment consists of a single shot which is made of special proteins called antibodies that bind to the site at ...

Cases of influenza continue to soar across Canada, meanwhile rates of respiratory syncytial virus, or RSV, and COVID-19 are ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

SPRINGFIELD/CHICAGO The Illinois Department of Public Health (IDPH) announced that after a one-week dip, the state’s overall ...

Health officials said there were three times as many hospital admissions for flu as there were for COVID-19 during the week ...